BridgeBio Pharma, Inc. (FRA:2CL)
Germany · Delayed Price · Currency is EUR 61.64
+0.22 (0.36%)
At close: Nov 28, 2025
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of €11.9 billion as of December 1, 2025. Its market cap has increased by 171.33% in one year.
Market Cap
11.90B
Enterprise Value
12.95B
Revenue
301.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
€61.64
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from 2.92B to 11.90B, an increase of 307.39%. That is a compound annual growth rate of 24.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 11.97B | 138.92% |
| Dec 31, 2024 | 5.01B | -21.16% |
| Dec 29, 2023 | 6.35B | 496.14% |
| Dec 30, 2022 | 1.07B | -50.63% |
| Dec 31, 2021 | 2.16B | -69.70% |
| Dec 31, 2020 | 7.13B | 84.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |